## NUE: Nucor Corporation - XLB: Basic Materials

### Executive Summary

VALUE thesis: PEG 0.75 indicates fundamental undervaluation. Consistent execution (3/4 quarters beat estimates). Caution: overbought RSI (72).

- **Horizon:** 20-60 days (position)
- **Risk Profile:** Lower - fundamental undervaluation
- **Stop Type:** Fixed 2xATR ($152.87)
- **If Wrong:** Exit if fundamentals deteriorate or stop hit
- **Invalidation:** PEG > 1.5 or earnings miss

### News

- **Articles:** 10
- **Sentiment:** Bullish (Bullish: 8, Bearish: 0)

**1. Nucor increases quarterly dividend to $0.56 per share By Investing.com**
- Source: Investing.com South Africa | 20251201T230200 | Bullish | Relevance: 99%
- Nucor Corporation announced a raise in its quarterly cash dividend to $0.56 per share, continuing a 53-year streak of annual increases. The steel manufacturer's shares have surged 47% in the past six months, despite an InvestingPro analysis indicating it's slightly overvalued. The company also reported strong Q3 2025 financial results, surpassing earnings expectations.

**2. BofA Sees Nucor (NUE) Well-Positioned for Long-Term Growth**
- Source: Finviz | 20251202T080600 | Bullish | Relevance: 99%
- BofA reaffirmed its Buy rating on Nucor (NUE) and raised its price target to $180, citing the company's strong third-quarter performance and positive long-term growth outlook. Despite a challenging macro environment, Nucor exceeded expectations with increased production and net income, driven by growth investments and its role in supplying materials for AI server cabinets. The company's focus on internal projects and acquisitions positions it well as North America's largest steel producer.

**3. Nucor Corporation $NUE Shares Sold by Grantham Mayo Van Otterloo & Co. LLC**
- Source: MarketBeat | 20251130T103527 | Somewhat-Bullish | Relevance: 98%
- Grantham Mayo Van Otterloo & Co. LLC significantly reduced its stake in Nucor Corporation ($NUE) by 22.2% in Q2 2025. Despite this sale, Nucor has received multiple analyst upgrades, with a consensus "Moderate Buy" rating and an average target price of $167.20. The company reported strong Q3 earnings, beating analyst expectations, and announced a quarterly dividend of $0.55.

**4. Nucor increases quarterly dividend to $0.56 per share**
- Source: Investing.com | 20251201T160100 | Bullish | Relevance: 98%
- Nucor Corporation announced an increase in its regular quarterly cash dividend to $0.56 per share, maintaining its 53-year streak of consecutive annual dividend increases. The dividend is payable on February 11, 2026, to stockholders of record as of December 31, 2025. Despite being slightly overvalued, Nucor's financial health is rated "GOOD" by InvestingPro, and the company recently reported strong Q3 2025 financial results, leading BMO Capital to raise its price target.

**5. Nucor (NYSE: NUE) raises dividend to $0.56, marking 211 consecutive payouts**
- Source: Stock Titan | 20251201T205100 | Bullish | Relevance: 98%
- Nucor (NYSE: NUE) announced an increase in its regular quarterly cash dividend to $0.56 per share, marking its 211th consecutive quarterly cash dividend. The dividend is payable on February 11, 2026, to stockholders of record on December 31, 2025. This increase continues Nucor's streak of raising its base dividend for 53 consecutive years, dating back to 1973.

### Analyst Activity

**Target Signal:** BULLISH (Raises: 3, Lowers: 0)

| Date | Firm | Target | Prior | Change |
|------|------|--------|-------|--------|
| 2025-12-10 | Jefferies | $190 | $170 | +12% |
| 2025-12-05 | JP Morgan | $200 | $175 | +14% |
| 2025-11-14 | Wells Fargo | $167 | $147 | +14% |

**Rating Changes:**

| Date | Firm | Action | Grade |
|------|------|--------|-------|
| 2025-12-10 | Jefferies | main | Buy |
| 2025-12-05 | JP Morgan | main | Overweight |
| 2025-11-14 | Wells Fargo | up | Overweight |

### Insider Activity (90 days)

| Metric | Value |
|--------|-------|
| Direction | **NET_SELLING** |
| Buys | 0 ($0.00M) |
| Sells | 3 ($2.12M) |

### Institutional Ownership

| Metric | Value |
|--------|-------|
| Total Ownership | 46.2% |
| Smart Money | **BULLISH** |
| Net Flow | 0.0% |
| Buying/Selling | 2 / 7 |

**Top Holders:**
- Vanguard Group Inc: 12.4% (-3.1%)
- State Farm Mutual Au: 10.6% (-0.7%)
- Blackrock Inc.: 8.1% (-3.6%)
- State Street Corpora: 5.3% (-2.7%)
- Berkshire Hathaway, : 2.8% (-3.1%)

### Key Risks

1. High beta (1.86) amplifies market volatility - any risk-off move could trigger sharp selloff.
2. Market regime shift could impact high-beta names disproportionately.
3. Sector rotation risk if leadership changes from current market theme.

### Catalysts

- Analyst target momentum: 3 raises (avg +13%) could attract flows.
- AI/machine learning initiatives could drive multiple expansion if executed.

### Fundamentals

PEG ratio 0.75 indicates undervaluation relative to growth. Forward P/E 14.0x attractive for 42% earnings growth. Balance sheet: strong liquidity (2.8x). Analyst sentiment positive (3 raises, avg +13%). Insider selling cluster ($2.1M in 90 days), potential headwind. Institutional flow bullish (2 buying vs 7 selling).

| Metric | Value |
|--------|-------|
| Market Cap | $37.6B |
| Beta | 1.86 |
| 52W Range | $97.59 - $166.27 |
| Short Interest | 2.2% |

| Valuation | Value |
|-----------|-------|
| PEG Ratio | 0.75 |
| Forward P/E | 14.0 |
| Current P/E | 19.9 |
| YoY Growth | 42.2% |
| EPS Direction | STABLE |

### Technicals

MRS_20 stable at 5.4% (minimal 5-day change). Currently in lower STRENGTH zone (4.0-10.0%), cross-sectional ranking at 92nd percentile. MRS_5 at 0.4% confirms short-term momentum alignment. AM_20 at 7.3% shows strong absolute momentum above own 20MA. Outperforming sector by 5.3pp, stock-specific strength. Full SMA alignment bullish (above 20/50/200 SMAs). MACD histogram positive (1.16), confirming momentum. RSI overbought at 72, risk of mean reversion.

| Metric | Value | Signal |
|--------|-------|--------|
| MRS_20 | 5.44% (CS: 92) | Strong |
| RSI_14 | 72.4 | Overbought |
| MACD Histogram | 1.16 | Bullish |
| vs SMA20 | 1.073x | Above |
| vs SMA50 | 1.122x | Above |
| vs SMA200 | 1.211x | Above |

### Decision

- **Verdict:** AVOID
- **Thesis:** VALUE

### Trade Setup

- **Entry:** $161.09
- **Stop Loss:** $152.87 (5.1% risk)
- **Target:** $177.53 (R:R method)
- **Risk/Reward:** 2.00:1
- **Target Reasoning:** VALUE thesis targets 2.0x risk/reward based on historical edge

### Position Sizing

- **Shares:** 121
- **Position Value:** $19,491.89
- **Portfolio %:** 19.49%
- **Risk Dollars:** $1,000.00
- **Risk Per Trade:** 1.00%
- **Modifiers:** L1 100% | L2 100% | Combined 1.00x

### Market Context

| Layer | Signal | Modifier |
|-------|--------|----------|
| L1 Macro | NORMAL (MEDIUM) | 1.00x |
| L2 Sector | NEUTRAL (Zone E) | 1.00x |

*NORMAL regime with moderate improvement trajectory. VIX compression from 20.5 to 16.6 over 5 days signals declining fear, while 47% breadth shows narrow but recovering participation. Fed meeting in 6 days creates near-term uncertainty, but AI sector momentum and improving technical setups support selective positioning.*

### Earnings

**Next:** 2026-01-26 (Est: $2.09)

| Quarter | Est | Actual | Surprise |
|---------|-----|--------|----------|
| 2025Q3 | $2.16 | $2.63 | +22.0% |
| 2025Q2 | $2.61 | $2.60 | -0.6% |
| 2025Q1 | $0.61 | $0.67 | +9.8% |
| 2024Q4 | $0.64 | $1.22 | +90.6% |

---
*RULE-based L3 | 2026-01-06 16:37 | MRS_20*